FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jennifer Graf

Research Profile

Procedures

Chemicals & Drugs

Phenomena

Metabolic Clearance Rate

Concepts & Ideas

Anatomy

Microsomes, Liver

Physiology

Drug Interactions

Co-author Network

Publications

TOP 3
David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; Steven M Fogelman; Gengsheng Chen; Jennifer A Graf; Polyxane Mertzanis; Susan Byron; Kerry E Culm; Brian W Granda; Johanna Daily; Richard I Shader
Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.
Karthik Venkatakrishnan; J Schmider; Jerold S Harmatz; Bruce L Ehrenberg; Lisa L Von Moltke; Jennifer A Graf; Polyxane Mertzanis; Kathleen E Corbett; M C Rodriguez; Richard I Shader; David J Greenblatt
Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Differential impairment of triazolam and zolpidem clearance by ritonavir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jennifer Graf (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; Steven M Fogelman; Gengsheng Chen; Jennifer A Graf; Polyxane Mertzanis; Susan Byron; Kerry E Culm; Brian W Granda; Johanna Daily; Richard I Shader
Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.
Journal of clinical pharmacology 2003;43(4):414-22.
2001: Karthik Venkatakrishnan; J Schmider; Jerold S Harmatz; Bruce L Ehrenberg; Lisa L Von Moltke; Jennifer A Graf; Polyxane Mertzanis; Kathleen E Corbett; M C Rodriguez; Richard I Shader; David J Greenblatt
Relative contribution of CYP3A to amitriptyline clearance in humans: in vitro and in vivo studies.
Journal of clinical pharmacology 2001;41(10):1043-54.
2000: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Differential impairment of triazolam and zolpidem clearance by ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2000;24(2):129-36.
2000: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Alprazolam-ritonavir interaction: implications for product labeling.
Clinical pharmacology and therapeutics 2000;67(4):335-41.
1998: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; Polyxane Mertzanis; Jennifer A Graf; AL Durol; M Counihan; B Roth-Schechter; Richard I Shader
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Clinical pharmacology and therapeutics 1998;64(6):661-71.
1998: David J Greenblatt; Jerold S Harmatz; Lisa L Von Moltke; Bruce L Ehrenberg; L Harrel; Kathleen E Corbett; M Counihan; Jennifer A Graf; Mona Darwish; Polyxane Mertzanis; PT Martin; WH Cevallos; Richard I Shader
Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Clinical pharmacology and therapeutics 1998;64(5):553-61.
1998: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; M Counihan; Jennifer A Graf; AL Durol; Polyxane Mertzanis; Su X Duan; C Eugene Wright; Richard I Shader
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Clinical pharmacology and therapeutics 1998;64(3):278-85.